Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old female rhesus monkeys
Animal research · 2015
- What was studied
- Nine old rhesus monkeys: five Pancragen, four glimepiride
- Main finding
- Compared glucose and endocrine responses with glimepiride; the groups showed different insulin/C-peptide patterns.
Reported findings and study design
Nine aged female rhesus macaques underwent glucose tolerance testing. Five received Pancragen 0.05 mg per animal intramuscularly each day for 10 days. Four received oral glimepiride 4 mg per animal daily for 10 days.
Population or model Nine old rhesus monkeys: five Pancragen, four glimepiride
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Basal glucose | Decreased in both groups. | |
| Insulin and C-peptide during glucose testing | The authors reported normalization with Pancragen. Glimepiride had a later glucose-lowering effect and stimulated C-peptide, with no significant effect on insulin secretion. The abstract does not give the effect sizes. |
Source for these results ↗ · Reviewed 2026-11-16
Study limitations and source details
Study limitations
- Very small animal comparison; not a head-to-head human diabetes trial.
- Full methods, adverse-event reporting and independent replication remain to be appraised.
Source details
Journal publication
Europe PMC indexed citation and abstract checked. Full original paper not reviewed.
Sources checked
Citation
Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology
Goncharova ND, Ivanova LG, Oganyan TE, Vengerin AA, Khavinson VK. Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old female rhesus monkeys Advances in gerontology = Uspekhi gerontologii 28(3):579-585. PMID 28509500